We are monitoring the impact of COVID-19 & Recession alarm on Biopharmaceuticals Market Get in touch with us for detailed analysis Know More

Know More

Share on

Global Biopharmaceuticals Market Size, Share, Trends, Growth, COVID-19 Impact Analysis Report - Segmented By Product Type, Therapeutic Type and Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 581
Pages: 175

Global Biopharmaceuticals Market Size (2022 to 2027)

As per our research report, the global biopharmaceutical market is estimated to grow at a CAGR of 9.2% during the forecast period. The market size was worth USD 210.17 billion in 2022 and is forecasted to be worth USD 326.3 billion by 2027. Companies such as Amgen Inc., AbbVie Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, and Novo Nordisk are forecasted to account for a significant biopharmaceuticals market share in the global market during the forecast period.

Disease treatment techniques have been revolutionized using Biopharmaceuticals or biologics because of their efficiency against autoimmune diseases & cancer and better mode of action. Therefore, the healthcare industry is expected to shift from traditional small molecule drugs to Biopharmaceuticals.

COVID-19 has shown a mixed impact on the biopharmaceuticals market.

COVID-19 has a significant impact on every medical industry, likewise biopharmaceuticals. The disruptive effects of COVID-19 have placed enormous strain on the global supply of pharmaceutical products, biologics, and biological preparations. Manufacturing devices and preparative materials such as API, etc., faced a supply shortage due to the crisis in COVID-19. Most of the materials and devices necessary are expected to get delivered on time but are affected due to the COVID-19 pandemic. As most manufacturers are from China, this affected the market growth in all other countries and slowed production. Due to the pandemic crisis still going, it impacted research and developmental activities. Many organizations have held the funds. Researchers, scientists, doctors, and other staff are the most affected set of people by COVID-19.

However, the growth rate of the biopharmaceuticals market is expected to be accelerated as most market participants are involved completely in developing the vaccine for COVID-19 in the near future.

The rising geriatric population prone to neurodegenerative and autoimmune disorders provides a strong business base to the global biopharmaceuticals market.

There is a massive demand for biopharmaceuticals due to the increasing incidence of chronic diseases whose treatment is possible using these drugs. Additionally, the other major drivers contributing to the growth of the global biopharmaceuticals market are the increased geriatric population globally and the rise in the prevalence of chronic conditions. Furthermore, an increase in the occurrence of vulnerable diseases such as cancer and diabetes, growth in obesity and sedentary lifestyle among the population, and growing acceptance of biopharmaceuticals due to their ability to treat previously untreatable diseases are further significantly driving the market growth. According to WHO, cancer is the leading cause of death globally, and diabetic patients are also increasing daily due to lifestyle changes. A sedentary lifestyle leads to several chronic diseases, thus boosting the market growth. Biopharmaceuticals hold the potential to cure the disease entirely and not just the symptoms, hence increasing its acceptance.

Side effects associated with the over-consumption of drugs and the high manufacturing cost hamper the biopharmaceuticals market growth.

High costs associated with the drug development process are significant restraints to the biopharmaceuticals market. The threat of failure of drugs and challenging developments affects market growth. With a price of 100 million USD, it generally takes 5 to 9 years to develop a biopharmaceutical product. This regulatory framework for establishment takes over a lot of work and patience. World Health Organization (WHO) also has set strict approval standards for biopharmaceuticals, which is further estimated to restrict the growth scope of the market to some extent.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Product Type, Therapeutic Type, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East, and Africa

 

This research report on the global biopharmaceuticals market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2026.

Biopharmaceuticals Market – By Product Type:

  • Monoclonal Antibodies (mAb)       
  • Erythropoietin       
  • Biotech Vaccines  
  • Recombinant Human (RH) Insulin 
  • Granulocyte colony-stimulating factor (G-CSF)       
  • Interferon               
  • Human Growth Hormones (HGH)  

The monoclonal antibodies segment is estimated to lead the global biopharmaceuticals market based on the product type during the forecast period. Monoclonal antibodies are the technology that is the most emerging. Monoclonal antibodies are identical to immune cells and represent a copy of the unique parent cell. Monoclonal antibodies alone contribute 40% of the global biopharmaceutical market.

Biopharmaceuticals Market – By Therapeutic Type:

  • Neurology               
  • Infectious diseases              
  • Diabetes  
  • Oncology 
  • Cardiovascular       
  • Other Therapeutic Areas  

In terms of therapeutic application, oncology was the largest segment in the biopharmaceutical market in 2021.

Biopharmaceuticals Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America was the largest market for biopharmaceuticals globally in 2021. Technological advancements in the region are propelling the dominance of the region. In North America, the United States biopharmaceuticals market holds the largest market share of 46%, followed by Canada.

In the forecast period, Asia-Pacific is forecasted to develop as the fastest-growing region in the global Biopharmaceuticals market. Increasing awareness regarding biological drugs is driving the market in the area. Asia-Pacific is expected to grow steadily at a CAGR of 8.34% throughout the forecast. Because of an increase in R&D investment, a rise in the adoption and availability of biopharmaceuticals for disease treatment, and a surge in disease diagnosis awareness. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms conduct over half the world's research and development(R&D) in pharmaceuticals and hold the intellectual property rights on most new medicines. The LAMEA region is also expected to boost market growth. Europe is the second-largest Biopharmaceuticals market in the world. The European biopharmaceutical market alone is projected to increase by USD 44.26 billion in 2020 and is estimated to grow at a CAGR of 8.89% to reach USD 67.76 billion by 2025.

KEY MARKET PLAYERS:

List of crucial competitors dominating the global Biopharmaceuticals market profiled in this report are Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc. and Novartis AG.

RECENT HAPPENINGS IN THE MARKET:

  • In January 2021, Pfizer Inc. and Biopharmaceutical New Technologies (BioNTech) developed a COVID 19 vaccine. As a result, these two biopharmaceutical companies become the first to receive emergency validation from the WHO. 
  • In September 2020, Sanofi and GlaxoSmithKline Plc collaborated to develop a COVID 19 vaccine. The vaccine developed is ready to begin human trials. These two vaccine makers have started their trials across 11 sites in the United States.
  • In December 2020, Amgen Inc. acquired a drug known as AMG634 and bought Otezla from Celgene in 2019 for $13.4 billion. In addition, Amgen Inc. has received a license to treat tuberculosis and leprosy, one of the investigational pipeline drugs to Medicines Development for Global Health.
  • In July 2020, SomaLogic enlarged its collaboration to discover a new drug with giant biopharmaceutical Amgen Inc. SomaLogic uses more than 40,000 blood samples to quantity different biomarkers for clinical trial patients.
  • In August 2020, Biogen’s BLA Aducanumab accepted the FDA's priority review for Alzheimer’s diseases, co-developing with Eisai. This will be the first therapy for the clinical decline in Alzheimer’s disease if the drug is approved.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 South Korea           

                                6.3.6 Australia   

                6.4 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Mexico     

                                6.4.4 Argentina

                                6.4.5 Rest of Latin America          

                6.5 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Global Biopharmaceuticals Market, By Region, From 2022 - 2027 (USD Billion)
  2. Global Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  3. Global Monoclonal Antibodies (mAb) Market, By Region, From 2022 - 2027 (USD Billion)
  4. Global Erythropoietin Market, By Region, From 2022 - 2027 (USD Billion)
  5. Global Biotech Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  6. Global Recombinant Human (RH) Insulin Market, By Region, From 2022 - 2027 (USD Billion)
  7. Global Granulocyte colony-stimulating factor (G-CSF) Market, By Region, From 2022 - 2027 (USD Billion)
  8. Global Interferon Market, By Region, From 2022 - 2027 (USD Billion)
  9. Global Human growth hormones (HGH) Market, By Region, From 2022 - 2027 (USD Billion)
  10. Global Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  11. Global Neurology Market, By Region, From 2022 - 2027 (USD Billion)
  12. Global Infectious diseases Market, By Region, From 2022 - 2027 (USD Billion)
  13. Global Diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  14. Global Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  15. Global Cardiovascular Market, By Region, From 2022 - 2027 (USD Billion)
  16. Global Other Therapeutic Areas Market, By Region, From 2022 - 2027 (USD Billion)
  17. North America Biopharmaceuticals Market, By Region, From 2022 - 2027 (USD Billion)
  18. North America Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  19. North America Monoclonal Antibodies (mAb) Market, By Region, From 2022 - 2027 (USD Billion)
  20. North America Erythropoietin Market, By Region, From 2022 - 2027 (USD Billion)
  21. North America Biotech Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  22. North America Recombinant Human (RH) Insulin Market, By Region, From 2022 - 2027 (USD Billion)
  23. North America Granulocyte colony-stimulating factor (G-CSF) Market, By Region, From 2022 - 2027 (USD Billion)
  24. North America Interferon Market, By Region, From 2022 - 2027 (USD Billion)
  25. North America Human growth hormones (HGH) Market, By Region, From 2022 - 2027 (USD Billion)
  26. North America Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  27. North America Neurology Market, By Region, From 2022 - 2027 (USD Billion)
  28. North America Infectious diseases Market, By Region, From 2022 - 2027 (USD Billion)
  29. North America Diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  30. North America Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  31. North America Cardiovascular Market, By Region, From 2022 - 2027 (USD Billion)
  32. North America Other Therapeutic Areas Market, By Region, From 2022 - 2027 (USD Billion)
  33. United States Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  34. United States Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  35. Canada Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  36. Canada Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  37. Europe Biopharmaceuticals Market, By Region, From 2022 - 2027 (USD Billion)
  38. Europe Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  39. Europe Monoclonal Antibodies (mAb) Market, By Region, From 2022 - 2027 (USD Billion)
  40. Europe Erythropoietin Market, By Region, From 2022 - 2027 (USD Billion)
  41. Europe Biotech Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  42. Europe Recombinant Human (RH) Insulin Market, By Region, From 2022 - 2027 (USD Billion)
  43. Europe Granulocyte colony-stimulating factor (G-CSF) Market, By Region, From 2022 - 2027 (USD Billion)
  44. Europe Interferon Market, By Region, From 2022 - 2027 (USD Billion)
  45. Europe Human growth hormones (HGH) Market, By Region, From 2022 - 2027 (USD Billion)
  46. Europe Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  47. Europe Neurology Market, By Region, From 2022 - 2027 (USD Billion)
  48. Europe Infectious diseases Market, By Region, From 2022 - 2027 (USD Billion)
  49. Europe Diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  50. Europe Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  51. Europe Cardiovascular Market, By Region, From 2022 - 2027 (USD Billion)
  52. Europe Other Therapeutic Areas Market, By Region, From 2022 - 2027 (USD Billion)
  53. U.K Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  54. U.K Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  55. Spain Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  56. Spain Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  57. Germany Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  58. Germany Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  59. Italy Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  60. Italy Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  61. France Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  62. France Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  63. Asia-Pacific Biopharmaceuticals Market, By Region, From 2022 - 2027 (USD Billion)
  64. Asia-Pacific Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  65. Asia-Pacific Monoclonal Antibodies (mAb) Market, By Region, From 2022 - 2027 (USD Billion)
  66. Asia-Pacific Erythropoietin Market, By Region, From 2022 - 2027 (USD Billion)
  67. Asia-Pacific Biotech Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  68. Asia-Pacific Recombinant Human (RH) Insulin Market, By Region, From 2022 - 2027 (USD Billion)
  69. Asia-Pacific Granulocyte colony-stimulating factor (G-CSF) Market, By Region, From 2022 - 2027 (USD Billion)
  70. Asia-Pacific Interferon Market, By Region, From 2022 - 2027 (USD Billion)
  71. Asia-Pacific Human growth hormones (HGH) Market, By Region, From 2022 - 2027 (USD Billion)
  72. Asia-Pacific Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  73. Asia-Pacific Neurology Market, By Region, From 2022 - 2027 (USD Billion)
  74. Asia-Pacific Infectious diseases Market, By Region, From 2022 - 2027 (USD Billion)
  75. Asia-Pacific Diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  76. Asia-Pacific Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  77. Asia-Pacific Cardiovascular Market, By Region, From 2022 - 2027 (USD Billion)
  78. Asia-Pacific Other Therapeutic Areas Market, By Region, From 2022 - 2027 (USD Billion)
  79. China Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  80. China Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  81. India Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  82. India Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  83. Japan Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  84. Japan Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  85. South Korea Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  86. South Korea Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  87. Australia Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  88. Australia Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  89. Latin America Biopharmaceuticals Market, By Region, From 2022 - 2027 (USD Billion)
  90. Latin America Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  91. Latin America Monoclonal Antibodies (mAb) Market, By Region, From 2022 - 2027 (USD Billion)
  92. Latin America Erythropoietin Market, By Region, From 2022 - 2027 (USD Billion)
  93. Latin America Biotech Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  94. Latin America Recombinant Human (RH) Insulin Market, By Region, From 2022 - 2027 (USD Billion)
  95. Latin America Granulocyte colony-stimulating factor (G-CSF) Market, By Region, From 2022 - 2027 (USD Billion)
  96. Latin America Interferon Market, By Region, From 2022 - 2027 (USD Billion)
  97. Latin America Human growth hormones (HGH) Market, By Region, From 2022 - 2027 (USD Billion)
  98. Latin America Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  99. Latin America Neurology Market, By Region, From 2022 - 2027 (USD Billion)
  100. Latin America Infectious diseases Market, By Region, From 2022 - 2027 (USD Billion)
  101. Latin America Diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  102. Latin America Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  103. Latin America Cardiovascular Market, By Region, From 2022 - 2027 (USD Billion)
  104. Latin America Other Therapeutic Areas Market, By Region, From 2022 - 2027 (USD Billion)
  105. Brazil Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  106. Brazil Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  107. Argentina Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  108. Argentina Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  109. Mexico Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  110. Mexico Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  111. Middle East & Africa Biopharmaceuticals Market, By Region, From 2022 - 2027 (USD Billion)
  112. Middle East & Africa Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  113. Middle East & Africa Monoclonal Antibodies (mAb) Market, By Region, From 2022 - 2027 (USD Billion)
  114. Middle East & Africa Erythropoietin Market, By Region, From 2022 - 2027 (USD Billion)
  115. Middle East & Africa Biotech Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  116. Middle East & Africa Recombinant Human (RH) Insulin Market, By Region, From 2022 - 2027 (USD Billion)
  117. Middle East & Africa Granulocyte colony-stimulating factor (G-CSF) Market, By Region, From 2022 - 2027 (USD Billion)
  118. Middle East & Africa Interferon Market, By Region, From 2022 - 2027 (USD Billion)
  119. Middle East & Africa Human growth hormones (HGH) Market, By Region, From 2022 - 2027 (USD Billion)
  120. Middle East & Africa Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  121. Middle East & Africa Neurology Market, By Region, From 2022 - 2027 (USD Billion)
  122. Middle East & Africa Infectious diseases Market, By Region, From 2022 - 2027 (USD Billion)
  123. Middle East & Africa Diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  124. Middle East & Africa Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  125. Middle East & Africa Cardiovascular Market, By Region, From 2022 - 2027 (USD Billion)
  126. Middle East & Africa Other Therapeutic Areas Market, By Region, From 2022 - 2027 (USD Billion)
  127. Middle East Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  128. Middle East Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)
  129. Africa Biopharmaceuticals Market, By Product Type, From 2022 - 2027 (USD Billion)
  130. Africa Biopharmaceuticals Market, By Therapeutic Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

FAQ's

How much was the global allergy biopharmaceuticals market worth in 2021?

The global biopharmaceuticals market size was valued at USD 192.46 billion in 2021.

Which segment by product led the biopharmaceuticals market in 2021?

The monoclonal antibodies segment accounted for the major share of the global biopharmaceuticals market in 2021.

Which region dominated the market for biopharmaceuticals worldwide in 2021?

Geographically, the North American region dominated the biopharmaceuticals market worldwide in 2021.

Who are the major players in the biopharmaceuticals market?

Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc. and Novartis AG are some of the notable players in the biopharmaceuticals market.

Related Reports

PURCHASE OPTIONS

pdf
$

4255


pdf excel
$

5060


pdf excel powerbi
$

7360


excel
$

2500

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample